乌鸦传媒

<乌鸦传媒 class="page-title">Meeting Coverage

AHA Video Pearls: Lipid Management

<乌鸦传媒 class="page-description">Lipid Management Video Pearls from the American Heart Association
Icosapent Ethyl Linked to Reduced Risk of Cardiovascular Events

Deepak Bhatt, MD, MPH, makes the case that RESPECT-EPA was a "positive trial"

image
<乌鸦传媒 class="section_title">Latest AHA Video Pearls: Lipid Management Meeting Coverage
Pemafibrate Lowers Triglyceride Levels, but Doesn't Reduce CV Risks

Aruna Pradhan, MD, discusses the results of the PROMINENT trial

November 29, 2022
Profound and Sustained Reductions in Lipoprotein(a) With Olpasiran

Michelle O'Donoghue, MD, says there was a "tremendous amount of enthusiasm" at AHA meeting

November 22, 2022
RNA Inhibitor Shows Early Efficacy, Safety in Adults With Mixed Dyslipidemia

ARO-ANG3 also demonstrated dose-dependent reduction in hepatic fat by MRI

November 15, 2022
Statins and Placebo Produce Similar Side Effects

Maryann McLaughlin, MD, addresses the "nocebo effect" found in SAMSON

December 15, 2020
Novel Monoclonal Antibody Halves LDL Cholesterol Levels

Evinacumab safe and effective in patients with refractory hypercholesterolemia

December 8, 2020
Negative Fish Oil Studies Shouldn't Diminish REDUCE-IT

Deepak Bhatt, MD, says not all omega-3 fatty acid formulations are created equal

December 1, 2020
STRENGTH Trial Disheartening for Fish Oil Craze

Steven Nissen on the disparate results with omega-3 products

November 24, 2020
<乌鸦传媒 class="section_title"> Latest Cardiology Meeting Coverage